bluebox home | Research commercialisation | Information for investors and industry | Start-up companies
A key strategy in the management of QUT's intellectual capital is the creation of new start-up companies. bluebox manages these activities via its guidance in identification and sourcing of investment, company/project management and board participation.
Most recently, intellectual property developed at QUT has been integral in the creation of many companies, four of which are highlighted below:
- Tissue Therapies Ltd
, with key technologies in novel growth factors and autologous cell therapies - Impedimed Ltd , a medical device company focusing on bioimpedance
- Farmacule Bioindustries Pty Ltd , which is a molecular farming company
- Evogenix Ltd provides advanced technologies to provide powerful new antibody therapeutics for world markets.
DISCLAIMER: Content on this website is for information purposes only. It does not constitute nor is it intended to constitute the provision of financial product advice. You must conduct your own due diligence on any companies / technologies before making an investment. Please read our full disclaimer.
